Aquestive Therapeutics, Inc.
NASDAQAquestive Therapeutics reports Q1 results today with a notable insider selling cluster dominating the pre-earnings backdrop. The insider signal is the sharpest data point heading in. Five executives — including the CEO, CFO, COO, and Chief Legal Officer — sold shares on May 5, just nine days before today's print. CEO Daniel Barber sold 335,922 shares at $4.18, netting roughly $1.4…
Snapshot as of 14 May 2026
Aquestive Therapeutics reports Q1 results today with a notable insider selling cluster dominating the pre-earnings backdrop. The insider signal is the sharpest data point heading in. Five executives — including the…
Aquestive Therapeutics heads into its Q1 earnings release tomorrow with the entire C-suite having sold shares within the past week — a cluster of insider exits that frames everything else on the tape. The insider…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AQST — free to start on ORTEX.
Sign up for free →Open AQST on ORTEX